To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene TBC1D2BTABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
349 supporting clones for gene TBC1D2B back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BU602523 mixed (pool of 40 RNAs) .a 1 to 435 1 to 436   tiling clone,   436/816
(53 %)
4 diff
(99.6 %id)
NM_144572.1   .a 75 to 6140 1 to 6066 exact RefSeq, AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 6066/6066
(100 %)
0 diff
(100 %id)
AW977238   .a 133 to 709 2 to 579       578/579
(99 %)
18 diff
(96.9 %id)
AI264315 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 138 to 568 1 to 431     Submitted on the opposite strand 431/431
(100 %)
3 diff
(99.4 %id)
AI381698 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 138 to 417 1 to 280     Submitted on the opposite strand 280/285
(98 %)
1 diff
(99.7 %id)
AI598196 anaplastic oligodendroglioma, brain .a 138 to 665 1 to 528     Submitted on the opposite strand 528/528
(100 %)
0 diff
(100 %id)
AI801994 carcinoid, lung .a 138 to 725 1 to 581     Submitted on the opposite strand 581/582
(99 %)
9 diff
(98.5 %id)
AI807585 carcinoid, lung .a 138 to 607 1 to 471     Submitted on the opposite strand 471/471
(100 %)
8 diff
(98.4 %id)
AI796054 Kidney .a 138 to 489 1 to 353     Submitted on the opposite strand 353/353
(100 %)
2 diff
(99.5 %id)
BE045328 carcinoid, lung .a 138 to 645 1 to 508     Submitted on the opposite strand 508/508
(100 %)
1 diff
(99.9 %id)
AW135485   .a 139 to 561 1 to 423     Submitted on the opposite strand 423/423
(100 %)
0 diff
(100 %id)
AW139835   .a 139 to 585 1 to 447     Submitted on the opposite strand 447/447
(100 %)
0 diff
(100 %id)
BE504351 carcinoid, lung .a 139 to 726 1 to 588     Submitted on the opposite strand 588/588
(100 %)
0 diff
(100 %id)
AW275348 Kidney .a 154 to 629 1 to 476     Submitted on the opposite strand 476/476
(100 %)
1 diff
(99.8 %id)
N72001 melanocyte .a 160 to 400 1 to 237     Submitted on the opposite strand 237/243
(97 %)
10 diff
(95.9 %id)
AA890263 parathyroid gland, parathyroid tumor .a 182 to 653 1 to 467     Submitted on the opposite strand 467/467
(100 %)
7 diff
(98.6 %id)
AA287710 germinal center B cell .a 190 to 676 1 to 480     Submitted on the opposite strand 480/480
(100 %)
9 diff
(98.2 %id)
DB279183 uterus .a 200 to 689 2 to 491   capped   490/490
(100 %)
0 diff
(100 %id)
AA732466 germinal center B cell .a 210 to 701 1 to 482     Submitted on the opposite strand 482/482
(100 %)
11 diff
(97.8 %id)
DB283854 uterus .a 220 to 757 2 to 538   capped   537/537
(100 %)
0 diff
(100 %id)
BF115701 fibrotheoma, ovary .a 231 to 887 657 to 2       656/657
(99 %)
4 diff
(99.4 %id)
DR007230 testis .a 285 to 960 8 to 681       674/682
(98 %)
12 diff
(98.3 %id)
TI_154195523   .a 343 to 1303 6 to 962       932/1059
(88 %)
58 diff
(94.6 %id)
TI_154196771   .a 343 to 1265 17 to 938       922/1104
(83 %)
47 diff
(95.8 %id)
TI_154197155   .a 343 to 1253 91 to 993   tiling clone,   903/1031
(87 %)
27 diff
(97.4 %id)
TI_985974075.
matches multiple genes
  .a 348 to 758 911 to 497     also hits gene FER1L6 415/1073
(38 %)
14 diff
(98.7 %id)
TI_1968230235   .a 429 to 1515 82 to 1178       1107/1316
(84 %)
73 diff
(94.5 %id)
BC140766 Brain, cerebellum, PCR rescued clones .a 430 to 5069 1 to 4639   tiling clone,   4639/4639
(100 %)
3 diff
(100.0 %id)
BC144482 Brain, cerebellum, PCR rescued clones .a 430 to 5069 1 to 4639       4639/4639
(100 %)
6 diff
(99.9 %id)
DR980780 placenta .a 512 to 881 1 to 362   AAA Submitted on the opposite strand 362/371
(97 %)
13 diff
(96.5 %id)
BF897465 marrow .a 568 to 806 247 to 13     Submitted on the opposite strand 235/247
(95 %)
1 diff
(99.6 %id)
BF897474 marrow .a 568 to 812 254 to 13     Submitted on the opposite strand 242/254
(95 %)
1 diff
(99.7 %id)
TI_2194697643   .a 597 to 1748 1145 to 9       1137/1297
(87 %)
13 diff
(99.0 %id)
DA768894 brain .a 597 to 1118 2 to 523   capped   522/522
(100 %)
0 diff
(100 %id)
N99436 melanocyte .a 623 to 872 279 to 29   AAA Submitted on the opposite strand 251/264
(95 %)
5 diff
(98.2 %id)
DA408388 thalamus .a 742 to 1294 2 to 554   capped   553/553
(100 %)
6 diff
(99.0 %id)
DB088456 testis .a 851 to 1389 2 to 541   capped   540/540
(100 %)
1 diff
(99.9 %id)
TI_1968230741   .a 920 to 2053 22 to 1149       1131/1265
(89 %)
19 diff
(98.5 %id)
BM043250 carcinoma, cell line, Prostate .a 1121 to 1721 1 to 603       603/738
(81 %)
10 diff
(98.7 %id)
BM043998 carcinoma, cell line, Prostate .a 1121 to 1721 1 to 601       601/787
(76 %)
7 diff
(99.2 %id)
BM047092 carcinoma, cell line, Prostate .a 1121 to 1721 1 to 601       601/659
(91 %)
7 diff
(99.0 %id)
BM047840 carcinoma, cell line, Prostate .a 1121 to 1721 1 to 602       602/721
(83 %)
9 diff
(98.8 %id)
BC094812 Prostate, carcinoma .a 1122 to 1721 1 to 600   AAA   600/1304
(46 %)
6 diff
(99.6 %id)
BQ937210 carcinoma, cell line, Prostate .a 1123 to 1721 1 to 599       599/974
(61 %)
6 diff
(99.4 %id)
BQ930999 carcinoma, cell line, Prostate .a 1123 to 1721 1 to 599       599/963
(62 %)
6 diff
(99.4 %id)
TI_2194697640   .a 1186 to 2058 887 to 16       872/1212
(71 %)
59 diff
(95.2 %id)
BC033712 Duodenum, adenocarcinoma .a 1303 to 6140 12 to 4848   available from MGC, AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 4837/4837
(100 %)
4 diff
(100.0 %id)
BF981485 duodenal adenocarcinoma, cell line, small intestine .a 1304 to 2039 1 to 737   available from MGC,   737/1033
(71 %)
14 diff
(98.7 %id)
BF828914 head_normal .a 1386 to 1741 22 to 376       355/376
(94 %)
9 diff
(97.7 %id)
CN483854 eye .a 1592 to 2139 1 to 548       548/548
(100 %)
0 diff
(100 %id)
BU521499 leiomyosarcoma, uterus .a 1650 to 2510 1 to 871       872/886
(98 %)
20 diff
(97.8 %id)
DB147803 thymus .a 1711 to 2275 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
CO249208 Chondrosarcoma Lung Metastasis cell lines, lung .a 1713 to 2335 8 to 630       623/747
(83 %)
15 diff
(98.0 %id)
BF918555 nervous_tumor .a 1718 to 2117 416 to 15     Submitted on the opposite strand 402/416
(96 %)
1 diff
(99.8 %id)
TI_2194697618   .a 1728 to 2698 969 to 8       962/1243
(77 %)
51 diff
(95.9 %id)
BI008652 kidney_tumor .a 1732 to 2131 24 to 422       399/422
(94 %)
6 diff
(98.6 %id)
AA287709 germinal center B cell .a 1766 to 2256 491 to 1     Submitted on the opposite strand 491/491
(100 %)
6 diff
(98.8 %id)
BF737795 bladder_tumor .a 1824 to 2081 1 to 258       258/258
(100 %)
2 diff
(99.3 %id)
BI023686 marrow .a 1857 to 2249 395 to 1       395/395
(100 %)
9 diff
(97.8 %id)
TI_2194695408   .a 1869 to 2993 1 to 1119       1119/1276
(87 %)
18 diff
(98.6 %id)
DB228555 trachea .a 2007 to 2566 2 to 562   capped   561/561
(100 %)
1 diff
(99.9 %id)
BX509192   .a 2012 to 2418 1 to 407       407/407
(100 %)
0 diff
(100 %id)
DA315944 hippocampus .a 2142 to 2676 2 to 536   capped   535/535
(100 %)
2 diff
(99.7 %id)
TI_2194697621   .a 2149 to 3221 1077 to 11       1067/1252
(85 %)
6 diff
(99.6 %id)
CV810187 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 2268 to 2975 1 to 707       707/887
(79 %)
64 diff
(92.8 %id)
DB224441 trachea .a 2305 to 2839 2 to 536   capped   535/535
(100 %)
0 diff
(100 %id)
DB154801 thymus .a 2482 to 2969 2 to 489   capped   488/488
(100 %)
2 diff
(99.6 %id)
DB142749 thymus .a 2489 to 3024 2 to 537   capped   536/536
(100 %)
0 diff
(100 %id)
DB228120 trachea .a 2587 to 3118 2 to 534   capped   533/533
(100 %)
2 diff
(99.7 %id)
CN421081 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 2624 to 3340 1 to 716       716/716
(100 %)
7 diff
(99.1 %id)
DB156566 thymus .a 2659 to 3211 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
DB068850 testis .a 2665 to 3224 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
TI_2194697629   .a 2691 to 3712 1023 to 9       1015/1250
(81 %)
5 diff
(99.6 %id)
BM904256 lymph, lymphoma, cell line .a 2696 to 3609 1 to 917       917/980
(93 %)
12 diff
(98.8 %id)
DB137143 thymus .a 2699 to 2988 2 to 291   capped   290/290
(100 %)
1 diff
(99.7 %id)
DA724946   .a 2700 to 3225 2 to 527   capped   526/526
(100 %)
0 diff
(100 %id)
DA992999 synovial membrane tissue from rheumatioidarthritis .a 2701 to 3281 2 to 582   capped   581/581
(100 %)
0 diff
(100 %id)
DB159699 thymus .a 2701 to 3297 2 to 598   capped   597/597
(100 %)
0 diff
(100 %id)
DB292477 uterus .a 2701 to 3220 2 to 523   capped   522/522
(100 %)
2 diff
(99.7 %id)
DA581546 lung .a 2702 to 3259 2 to 559   capped   558/558
(100 %)
1 diff
(99.9 %id)
DA117975 cerebellum .a 2706 to 3252 2 to 548   capped   547/547
(100 %)
0 diff
(100 %id)
DA190602 amygdala .a 2706 to 3211 2 to 507   capped   506/506
(100 %)
0 diff
(100 %id)
DA191255 amygdala .a 2706 to 3284 2 to 581   capped   580/581
(99 %)
2 diff
(99.7 %id)
DB136697 thymus .a 2706 to 3215 2 to 511   capped   510/510
(100 %)
0 diff
(100 %id)
DB219589 trachea .a 2706 to 3256 2 to 552   capped   551/551
(100 %)
0 diff
(100 %id)
DA715510   .a 2707 to 3215 2 to 510   capped   509/509
(100 %)
0 diff
(100 %id)
DB220067 trachea .a 2707 to 3271 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
DA850822 placenta .a 2708 to 3225 2 to 520   capped   519/519
(100 %)
1 diff
(99.9 %id)
DA852452 placenta .a 2708 to 3255 2 to 549   capped   548/548
(100 %)
1 diff
(99.9 %id)
DA093521 cerebellum .a 2710 to 3400 2 to 692   capped   691/691
(100 %)
0 diff
(100 %id)
DA107323 cerebellum .a 2711 to 3262 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
DA543044   .a 2711 to 3265 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
BP291647 lung .a 2722 to 3292 1 to 571       571/581
(98 %)
2 diff
(99.7 %id)
DA193053 amygdala .a 2723 to 3258 2 to 537   capped   536/536
(100 %)
1 diff
(99.9 %id)
DA377261 thalamus .a 2723 to 3284 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
DA448137 tongue, tumor tissue .a 2723 to 3277 2 to 556   capped   555/555
(100 %)
1 diff
(99.9 %id)
DA834809 placenta .a 2723 to 3475 2 to 757   capped   756/774
(97 %)
10 diff
(98.8 %id)
DA865086 placenta .a 2723 to 3311 2 to 591   capped   590/590
(100 %)
1 diff
(99.9 %id)
DB130782 thymus .a 2723 to 3193 2 to 472   capped   471/471
(100 %)
0 diff
(100 %id)
DB153219 thymus .a 2723 to 3265 2 to 544   capped   543/543
(100 %)
0 diff
(100 %id)
DB156549 thymus .a 2723 to 3301 2 to 580   capped   579/579
(100 %)
0 diff
(100 %id)
DA109347 cerebellum .a 2724 to 3280 2 to 559   capped   558/558
(100 %)
2 diff
(99.7 %id)
DA811412 brain .a 2724 to 3206 2 to 484   capped   483/483
(100 %)
0 diff
(100 %id)
DA990200 synovial membrane tissue from rheumatioidarthritis .a 2724 to 3259 2 to 537   capped   536/536
(100 %)
1 diff
(99.9 %id)
DA112902 cerebellum .a 2725 to 3273 2 to 550   capped   549/549
(100 %)
0 diff
(100 %id)
DA246614 brain .a 2725 to 3271 2 to 549   capped   548/548
(100 %)
2 diff
(99.7 %id)
DA371666 thalamus .a 2725 to 3225 2 to 502   capped   501/501
(100 %)
0 diff
(100 %id)
DA755875   .a 2725 to 3307 2 to 584   capped   583/583
(100 %)
1 diff
(99.9 %id)
DA766217 tongue .a 2725 to 3295 2 to 572   capped   571/571
(100 %)
1 diff
(99.9 %id)
DA435982 tongue, tumor tissue .a 2726 to 3308 2 to 584   capped   583/583
(100 %)
0 diff
(100 %id)
DA767318 tongue .a 2726 to 3312 2 to 588   capped   587/587
(100 %)
0 diff
(100 %id)
DA196622 amygdala .a 2727 to 3285 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
DA213126 brain .a 2727 to 3074 2 to 349   capped   348/348
(100 %)
0 diff
(100 %id)
DA449778 tongue, tumor tissue .a 2727 to 3292 2 to 569   capped   568/568
(100 %)
2 diff
(99.7 %id)
DA449785 tongue, tumor tissue .a 2727 to 3294 2 to 570   capped   569/569
(100 %)
2 diff
(99.7 %id)
DA857047 placenta .a 2727 to 3270 2 to 546   capped   545/545
(100 %)
2 diff
(99.7 %id)
DA099481 cerebellum .a 2728 to 3284 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
DA989068 synovial membrane tissue from rheumatioidarthritis .a 2728 to 3295 2 to 569   capped   568/568
(100 %)
1 diff
(99.9 %id)
DA589710 lung .a 2729 to 3274 2 to 547   capped   546/546
(100 %)
0 diff
(100 %id)
DA439252 tongue, tumor tissue .a 2731 to 3285 2 to 556   capped   555/555
(100 %)
1 diff
(99.9 %id)
DA850713 placenta .a 2731 to 3259 2 to 530   capped   529/529
(100 %)
0 diff
(100 %id)
DB139175 thymus .a 2731 to 3308 2 to 579   capped   578/578
(100 %)
0 diff
(100 %id)
DB143265 thymus .a 2731 to 3268 2 to 540   capped   539/539
(100 %)
1 diff
(99.9 %id)
DA307724 hippocampus .a 2760 to 3313 2 to 556   capped   555/555
(100 %)
5 diff
(99.1 %id)
BE294330 muscle, rhabdomyosarcoma .a 2807 to 3439 1 to 631       631/653
(96 %)
14 diff
(97.9 %id)
BE296237 muscle, rhabdomyosarcoma .a 2809 to 3443 1 to 633       633/717
(88 %)
10 diff
(98.7 %id)
DA864460 placenta .a 2831 to 3096 2 to 267   capped   266/266
(100 %)
0 diff
(100 %id)
BP303563   .a 2843 to 3417 1 to 574       574/574
(100 %)
2 diff
(99.7 %id)
DB134882 thymus .a 2849 to 3351 2 to 504   capped   503/503
(100 %)
0 diff
(100 %id)
DB151005 thymus .a 2857 to 3318 2 to 463   capped   462/462
(100 %)
0 diff
(100 %id)
BF089166 head_neck .a 2928 to 3197 284 to 16       269/284
(94 %)
0 diff
(100 %id)
AW504893 lymph .a 2975 to 3402 8 to 435       428/435
(98 %)
6 diff
(98.7 %id)
TI_154161259   .a 2975 to 3678 76 to 767       692/741
(93 %)
26 diff
(96.5 %id)
TI_2194695410   .a 3016 to 4092 1 to 1075       1075/1247
(86 %)
5 diff
(99.6 %id)
TI_1968230739   .a 3026 to 4247 9 to 1216       1208/1274
(94 %)
6 diff
(99.6 %id)
DA834036 placenta .a 3048 to 3866 2 to 816   capped   815/816
(99 %)
11 diff
(98.7 %id)
BI021752 marrow .a 3053 to 3282 29 to 258       230/258
(89 %)
6 diff
(97.7 %id)
CD694724 normal nasopharynx .a 3071 to 3522 8 to 459       452/459
(98 %)
6 diff
(98.7 %id)
TI_2194697607   .a 3105 to 4196 1086 to 3       1084/1254
(86 %)
0 diff
(100 %id)
BE297647 muscle, rhabdomyosarcoma .a 3135 to 3706 28 to 600       573/601
(95 %)
3 diff
(99.6 %id)
BF306954 muscle, rhabdomyosarcoma .a 3143 to 3867 1 to 712       712/928
(76 %)
33 diff
(96.5 %id)
DA464768   .a 3151 to 3709 2 to 561   capped   560/560
(100 %)
1 diff
(99.9 %id)
BM016907 astrocytoma grade IV, cell line, brain .a 3158 to 3569 1 to 413       413/413
(100 %)
2 diff
(99.6 %id)
TI_59387146   .a 3159 to 3569 59 to 470       412/412
(100 %)
1 diff
(99.8 %id)
BP309959 brain .a 3197 to 3779 1 to 583       583/583
(100 %)
2 diff
(99.7 %id)
DA591106 lung .a 3201 to 3749 2 to 550   capped   549/549
(100 %)
0 diff
(100 %id)
CD558679 White Matter .a 3247 to 3995 1 to 751       751/937
(80 %)
11 diff
(98.9 %id)
R25468 placenta .a 3248 to 3596 1 to 363       363/372
(97 %)
15 diff
(96.0 %id)
BE018143 cervical carcinoma cell line, cervix .a 3258 to 3739 1 to 482       482/482
(100 %)
0 diff
(100 %id)
CX758916 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 3280 to 4000 1 to 721     Submitted on the opposite strand 721/722
(99 %)
3 diff
(99.6 %id)
TI_1968236177   .a 3306 to 4488 1180 to 3       1178/1267
(92 %)
0 diff
(100 %id)
TI_1968234397   .a 3320 to 4196 873 to 4       870/1065
(81 %)
0 diff
(100 %id)
DB004847 breast, tumor tissue .a 3373 to 3917 2 to 546   capped   545/545
(100 %)
1 diff
(99.9 %id)
DB139270 thymus .a 3380 to 3893 2 to 515   capped   514/514
(100 %)
0 diff
(100 %id)
AK074871   .a 3384 to 6140 1 to 2756   tiling clone, available from FLJ,   2756/2756
(100 %)
4 diff
(99.9 %id)
DA734580   .a 3385 to 4067 2 to 687   capped   686/766
(89 %)
16 diff
(98.0 %id)
TI_227713037   .a 3408 to 4329 987 to 87   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 901/990
(91 %)
20 diff
(98.0 %id)
DA529680 brain .a 3506 to 4115 2 to 611   capped   610/610
(100 %)
0 diff
(100 %id)
DB112201 thymus .a 3507 to 4073 2 to 568   capped   567/567
(100 %)
1 diff
(99.9 %id)
DB163961 thymus .a 3547 to 4142 2 to 597   capped   596/596
(100 %)
0 diff
(100 %id)
TI_149283491   .a 3553 to 4297 43 to 787     Submitted on the opposite strand 745/787
(94 %)
6 diff
(99.3 %id)
CB854576 lung, Primary Lung Epithelial Cells .a 3553 to 4145 7 to 599     Submitted on the opposite strand 593/599
(98 %)
8 diff
(98.7 %id)
DA869733 Prostate .a 3568 to 4110 2 to 544   capped   543/543
(100 %)
0 diff
(100 %id)
BP232090 muscle .a 3584 to 4170 1 to 584       584/584
(100 %)
3 diff
(99.5 %id)
CR990058 T-Lymphocytes .a 3632 to 4307 1 to 676       676/678
(99 %)
1 diff
(99.9 %id)
BQ009040 Chondrosarcoma, Left Pelvis .a 3635 to 4306 690 to 19   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 672/677
(99 %)
0 diff
(100 %id)
CD367384 Alveolar Macrophage, lung .a 3636 to 4329 712 to 19   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 694/694
(100 %)
0 diff
(100 %id)
CD651916 Embryonic Stem cells .a 3664 to 4458 12 to 796       785/838
(93 %)
16 diff
(98.1 %id)
TI_2194697927   .a 3759 to 4799 8 to 1042       1035/1244
(83 %)
6 diff
(99.6 %id)
DA847402 placenta .a 3764 to 4315 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
BM013383 brain, neuroblastoma, cell line .a 3786 to 4543 1 to 768       768/768
(100 %)
21 diff
(97.3 %id)
TI_59380201   .a 3787 to 4543 104 to 870       767/767
(100 %)
21 diff
(97.3 %id)
BE298182 muscle, rhabdomyosarcoma .a 3810 to 4366 1 to 557       557/557
(100 %)
0 diff
(100 %id)
CA396294 eye, RPE/choroid .a 3838 to 4392 1 to 554       554/554
(100 %)
1 diff
(99.9 %id)
BQ025641 placenta .a 3865 to 4398 550 to 16   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 535/535
(100 %)
2 diff
(99.7 %id)
BG258897 embryonal carcinoma, cell line, testis .a 3869 to 4551 1 to 691       691/902
(76 %)
45 diff
(95.1 %id)
AI652981 pooled germ cell tumors .a 3871 to 4308 443 to 6       438/443
(98 %)
0 diff
(100 %id)
TI_2194695406   .a 3913 to 5008 3 to 1090       1088/1284
(84 %)
6 diff
(99.6 %id)
AI347503 colon, colon tumor, RER+ .a 3916 to 4328 413 to 1       413/413
(100 %)
0 diff
(100 %id)
BP296443   .a 3921 to 4306 1 to 385   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 385/385
(100 %)
3 diff
(99.3 %id)
BE869884 adenocarcinoma, colon .a 3924 to 4575 1 to 648       648/648
(100 %)
5 diff
(99.3 %id)
AA604348 adrenal adenoma, adrenal gland .a 3948 to 4401 455 to 1       455/455
(100 %)
2 diff
(99.6 %id)
R26293 placenta .a 3959 to 4398 456 to 1       456/459
(99 %)
29 diff
(93.7 %id)
TI_2194694853   .a 3992 to 5069 1188 to 119       1070/1248
(85 %)
0 diff
(100 %id)
AW015036   .a 4012 to 4329 335 to 18   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 318/328
(96 %)
0 diff
(100 %id)
AA550840 adrenal adenoma, adrenal gland .a 4018 to 4402 386 to 1       386/386
(100 %)
2 diff
(99.5 %id)
DA155360 amygdala .a 4032 to 4589 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
DA710587   .a 4073 to 4637 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
AI819024 Kidney, renal cell tumor .a 4085 to 4303 219 to 1       219/219
(100 %)
0 diff
(100 %id)
DA070441 cerebellum .a 4143 to 4696 2 to 555   capped   554/556
(99 %)
3 diff
(99.5 %id)
BM472250 melanotic melanoma, skin .a 4156 to 4814 12 to 683       672/1100
(61 %)
23 diff
(98.0 %id)
CD517764 White Matter .a 4157 to 5039 1 to 893       893/941
(94 %)
35 diff
(96.3 %id)
BF893020 marrow .a 4168 to 4523 375 to 20     Submitted on the opposite strand 356/375
(94 %)
0 diff
(100 %id)
BM751604 Ascites, stomach .a 4168 to 4716 1 to 546       546/546
(100 %)
3 diff
(99.5 %id)
CD558611 White Matter .a 4183 to 4662 1 to 486       486/840
(57 %)
18 diff
(97.9 %id)
DA379113 thalamus .a 4224 to 4782 2 to 559   capped   558/558
(100 %)
2 diff
(99.7 %id)
BP326162 prostata .a 4254 to 4793 1 to 541       541/577
(93 %)
24 diff
(95.9 %id)
CN421080 embryonic stem cells, DMSO-treated H9 cellline .a 4264 to 4859 9 to 603       595/603
(98 %)
3 diff
(99.6 %id)
BG681789 skin, squamous cell carcinoma .a 4264 to 5021 1 to 749       749/749
(100 %)
14 diff
(98.2 %id)
DA647140 mammary gland .a 4293 to 5006 2 to 718   capped   717/717
(100 %)
10 diff
(98.7 %id)
BE730122 melanotic melanoma, skin .a 4310 to 5051 21 to 754       734/758
(96 %)
29 diff
(96.2 %id)
BE730488 melanotic melanoma, skin .a 4310 to 5111 25 to 814   tiling clone,   790/896
(88 %)
24 diff
(97.4 %id)
BE387538 melanotic melanoma, skin .a 4324 to 5013 41 to 734   tiling clone,   694/734
(94 %)
6 diff
(99.2 %id)
BG747033 adenocarcinoma cell line, colon .a 4390 to 4910 1 to 519       519/519
(100 %)
4 diff
(99.3 %id)
BG822105 adenocarcinoma cell line, colon .a 4390 to 5245 1 to 850       850/852
(99 %)
19 diff
(97.8 %id)
BF689628 melanotic melanoma, high MDR (cell line), skin .a 4405 to 4949 1 to 541       541/541
(100 %)
8 diff
(98.6 %id)
BM743047 stomach .a 4415 to 5069 1 to 653       653/653
(100 %)
5 diff
(99.3 %id)
BM745270 stomach .a 4415 to 4956 1 to 541       541/541
(100 %)
3 diff
(99.5 %id)
BM765533 stomach .a 4415 to 5073 1 to 658       658/658
(100 %)
5 diff
(99.3 %id)
BP327252 prostata .a 4416 to 4926 1 to 512       512/580
(88 %)
8 diff
(98.7 %id)
BG007662 placenta_normal .a 4475 to 4976 501 to 1       501/502
(99 %)
12 diff
(97.7 %id)
BF795304 lymph, lymphoma, cell line .a 4484 to 5120 5 to 655       651/996
(65 %)
6 diff
(99.4 %id)
DA603341   .a 4507 to 5291 2 to 782   capped   781/867
(90 %)
10 diff
(98.9 %id)
CD245040 White Matter .a 4529 to 5278 1 to 755       755/972
(77 %)
11 diff
(98.9 %id)
BF690532 melanotic melanoma, high MDR (cell line), skin .a 5391 to 6090 721 to 1       721/955
(75 %)
41 diff
(95.8 %id)
DB381091 placenta .a 5575 to 6137 564 to 1       564/564
(100 %)
17 diff
(97.0 %id)
DB361968 mammary gland .a 5583 to 6140 565 to 1       565/565
(100 %)
15 diff
(97.4 %id)
DB366692   .a 5596 to 6140 545 to 1       545/551
(98 %)
12 diff
(97.9 %id)
BE301624 cervical carcinoma cell line, cervix .a 5707 to 6136 431 to 2   tiling clone,   430/431
(99 %)
0 diff
(100 %id)
NM_015079.5   .b 1 to 6014 1 to 6014 exact RefSeq, AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 6014/6014
(100 %)
0 diff
(100 %id)
AB028978 brain .b 138 to 6014 1 to 5876   tiling clone, available from KIAA,   5876/5876
(100 %)
4 diff
(100.0 %id)
BC152465 Clones donated by Kazusa DNA Research Inst. .b 138 to 6014 1 to 5876   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 5876/5876
(100 %)
4 diff
(100.0 %id)
AK000173 colon .c 1 to 2345 1 to 2346 exact tiling clone, available from FLJ, AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 2346/2346
(100 %)
2 diff
(100.0 %id)
BQ009211 Chondrosarcoma, Left Pubic Bone .c 1629 to 2357 724 to 1       724/725
(99 %)
9 diff
(98.8 %id)
BM931351 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .c 1754 to 2345 1 to 592   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 592/592
(100 %)
1 diff
(99.9 %id)
AW593274 pooled .c 1876 to 2347 473 to 1       473/473
(100 %)
1 diff
(99.8 %id)
R87836 brain .c 1986 to 2335 352 to 1     Submitted on the opposite strand 352/352
(100 %)
5 diff
(98.6 %id)
BM542633 embryonal carcinoma, cell line, testis .d 1 to 831 1 to 830 R222G S226L E227Q S234T Q235R ... tiling clone,   830/1061
(78 %)
18 diff
(98.4 %id)
BM174953 hippocampus .e 1 to 509 15 to 523 exact tiling clone,   509/523
(97 %)
6 diff
(98.9 %id)
AL137303 testis .f-u 1 to 4393 1 to 4392 exact tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 4392/4392
(100 %)
7 diff
(99.9 %id)
DB149766 thymus .f-u 307 to 868 2 to 564   capped   563/563
(100 %)
3 diff
(99.5 %id)
AI208117   .f-u 348 to 624 20 to 296     Submitted on the opposite strand 277/296
(93 %)
6 diff
(98.0 %id)
DB278348 uterus .f-u 355 to 894 2 to 541   capped   540/540
(100 %)
2 diff
(99.7 %id)
DA797233 brain .f-u 417 to 805 2 to 390   capped   389/389
(100 %)
2 diff
(99.5 %id)
DB288233 uterus .f-u 417 to 963 2 to 548   capped   547/547
(100 %)
2 diff
(99.7 %id)
DA099046 cerebellum .f-u 622 to 1175 2 to 555   capped   554/554
(100 %)
3 diff
(99.5 %id)
CN421078 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .f-u 2836 to 3293 1 to 457       457/457
(100 %)
5 diff
(99.0 %id)
DB162721 thymus .f-u 2838 to 3294 2 to 458   capped   457/457
(100 %)
4 diff
(99.2 %id)
BG292429 bladder, transitional cell papilloma, cell line .f-u 2888 to 3568 1 to 674   tiling clone,   674/683
(98 %)
10 diff
(98.6 %id)
CN421077 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .f-u 2924 to 3167 1 to 243       243/243
(100 %)
4 diff
(98.4 %id)
CR590128 thymus .f-u 3018 to 4367 1 to 1350   tiling clone,   1350/1350
(100 %)
0 diff
(100 %id)
BX456663 thymus .f-u 3018 to 3670 1 to 650   fully sequenced,   650/650
(100 %)
7 diff
(99.0 %id)
TI_57146929   .f-u 3149 to 3733 27 to 620       594/620
(95 %)
7 diff
(98.9 %id)
BC015718 Uterus, leiomyosarcoma .f-u 3152 to 4391 1 to 1240   available from MGC, AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 1240/1240
(100 %)
2 diff
(99.9 %id)
BI760877 pooled colon, kidney, stomach .f-u 3152 to 3733 1 to 591       591/591
(100 %)
17 diff
(97.2 %id)
CN421079.
matches multiple genes
embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .f-u 3165 to 3600 1 to 436   tiling clone, also hits gene smawzoybu 436/436
(100 %)
2 diff
(99.6 %id)
AW961162.
matches multiple genes
  .f-u 3166 to 3498 1 to 333     also hits gene smawzoybu 333/333
(100 %)
26 diff
(92.2 %id)
BE881842 leiomyosarcoma, uterus .f-u 3172 to 3779 1 to 611   available from MGC,   611/859
(71 %)
49 diff
(94.3 %id)
H28257 breast .f-u 3180 to 3514 1 to 333       333/392
(84 %)
8 diff
(98.0 %id)
AL109773   .f-u 3181 to 4396 1 to 1216   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 1216/1216
(100 %)
5 diff
(99.6 %id)
BF238119 B-cells, primary B-cells from tonsils (cell line) .f-u 3185 to 3862 1 to 679       679/679
(100 %)
4 diff
(99.5 %id)
AW607102 head_neck .f-u 3234 to 3705 1 to 482       482/669
(72 %)
13 diff
(98.1 %id)
BM686222 eye, RPE and Choroid .f-u 3236 to 3628 162 to 554       393/489
(80 %)
6 diff
(98.8 %id)
BP263505 small intestine .f-u 3242 to 3825 1 to 584       584/584
(100 %)
0 diff
(100 %id)
BP323028 Pancreas .f-u 3316 to 3884 1 to 571       571/571
(100 %)
2 diff
(99.7 %id)
BG740652 skin .f-u 3318 to 4160 1 to 844       844/844
(100 %)
8 diff
(99.1 %id)
H42971 breast .f-u 3324 to 3811 1 to 493       493/495
(99 %)
20 diff
(96.0 %id)
CN390169 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .f-u 3358 to 3981 1 to 624       624/624
(100 %)
5 diff
(99.2 %id)
TI_227714315   .f-u 3418 to 4396 1051 to 96   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 956/971
(98 %)
37 diff
(96.2 %id)
BG682693 skin, squamous cell carcinoma .f-u 3423 to 4086 27 to 697       671/697
(96 %)
6 diff
(99.2 %id)
BG286429 bladder, transitional cell papilloma, cell line .f-u 3429 to 4189 1 to 750       750/848
(88 %)
16 diff
(98.2 %id)
AL080229 testis .f-u 3454 to 4393 1 to 940   available from DKFZ, AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 940/940
(100 %)
1 diff
(99.9 %id)
CN390170 embryonic stem cells, DMSO-treated H9 cellline .f-u 3462 to 4074 1 to 613       613/613
(100 %)
1 diff
(99.9 %id)
TI_154103874   .f-u 3553 to 4396 917 to 87   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 831/928
(89 %)
23 diff
(97.6 %id)
BX093103 lung .f-u 3555 to 4130 130 to 705       576/705
(81 %)
6 diff
(99.2 %id)
BQ448258 Knee, Osteoarthritic Cartilage .f-u 3633 to 4396 777 to 16   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 762/763
(99 %)
3 diff
(99.7 %id)
BX456662 thymus .f-u 3640 to 4367 718 to 1   fully sequenced,   718/718
(100 %)
14 diff
(98.1 %id)
AA127101 colon, tumor .f-u 3673 to 4044 1 to 372   fully sequenced,   372/372
(100 %)
3 diff
(99.2 %id)
AA374850 lung .f-u 3695 to 4040 1 to 347       347/354
(98 %)
2 diff
(99.5 %id)
CD365019 Alveolar Macrophage, lung .f-u 3698 to 4396 713 to 16   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 698/698
(100 %)
3 diff
(99.6 %id)
CA446067 Chondrosarcoma, Left Pelvis .f-u 3713 to 4396 700 to 16   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 685/687
(99 %)
2 diff
(99.8 %id)
CA428304 Bone, Subchondral Bone .f-u 3733 to 4393 679 to 19   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 661/661
(100 %)
1 diff
(99.9 %id)
CA412952 Chondrosarcoma Grade II, Left Pelvis .f-u 3733 to 4396 682 to 19   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 664/664
(100 %)
1 diff
(99.9 %id)
BM717177 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .f-u 3755 to 4396 1 to 642   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 642/642
(100 %)
2 diff
(99.7 %id)
TI_151777674   .f-u 3755 to 4396 83 to 737       655/1331
(49 %)
6 diff
(99.6 %id)
R48450 breast .f-u 3781 to 4113 1 to 340       340/343
(99 %)
7 diff
(98.0 %id)
TI_154029686   .f-u 3785 to 4397 734 to 127       608/874
(69 %)
0 diff
(100 %id)
AA447863 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .f-u 3789 to 4131 1 to 342       342/342
(100 %)
2 diff
(99.5 %id)
AA447864 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .f-u 3789 to 4334 1 to 546       546/546
(100 %)
1 diff
(99.9 %id)
AA318696 Spleen .f-u 3796 to 4060 1 to 266       266/266
(100 %)
3 diff
(98.9 %id)
BQ003213 Chondrosarcoma, Left Pelvis .f-u 3803 to 4395 609 to 17       593/609
(97 %)
0 diff
(100 %id)
BM995065 Chondrosarcoma, Left Pubic Bone .f-u 3814 to 4396 598 to 16   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 583/583
(100 %)
2 diff
(99.7 %id)
AI801533.
matches multiple genes
poorly differentiated adenocarcinoma withsignet ring cell features, stomach .f-u 3824 to 4391 615 to 54   tiling clone, AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base), also hits gene kawto 562/815
(68 %)
0 diff
(100 %id)
AJ712663 bone marrow .f-u 3844 to 4287 1 to 444       444/444
(100 %)
0 diff
(100 %id)
BQ003197 Chondrosarcoma, Left Pelvis .f-u 3870 to 4396 540 to 16   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 525/525
(100 %)
5 diff
(99.1 %id)
R28217 placenta .f-u 3871 to 4149 1 to 279       279/279
(100 %)
4 diff
(98.6 %id)
BQ020947 lung, Metastatic Chondrosarcoma .f-u 3878 to 4396 534 to 16   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 519/519
(100 %)
2 diff
(99.7 %id)
TI_154006766   .f-u 3880 to 4397 640 to 123       518/641
(80 %)
0 diff
(100 %id)
BE220729 malignant melanoma, metastatic to lymphnode, skin .f-u 3888 to 4239 352 to 1       352/352
(100 %)
0 diff
(100 %id)
TI_154012353   .f-u 3898 to 4396 615 to 117   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 499/499
(100 %)
1 diff
(99.8 %id)
AW300664 colon, moderately differentiated adenocarcinoma .f-u 3909 to 4239 331 to 1       331/331
(100 %)
0 diff
(100 %id)
AL041572 testis .f-u 3910 to 4366 457 to 1       457/457
(100 %)
2 diff
(99.6 %id)
BM987161 mixed .f-u 3910 to 4397 505 to 18       488/505
(96 %)
0 diff
(100 %id)
BF195608 fibrotheoma, ovary .f-u 3910 to 4396 487 to 1       487/487
(100 %)
0 diff
(100 %id)
BM662829 eye, RPE and Choroid .f-u 3910 to 4397 504 to 17       488/504
(96 %)
0 diff
(100 %id)
AW338701 adenocarcinoma, Pancreas .f-u 3912 to 4395 485 to 2       484/485
(99 %)
0 diff
(100 %id)
CA436159 lung, Metastatic Chondrosarcoma .f-u 3919 to 4396 493 to 16   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 478/478
(100 %)
1 diff
(99.8 %id)
TI_154114114   .f-u 3930 to 4391 576 to 115       462/576
(80 %)
0 diff
(100 %id)
N93328 lung .f-u 3933 to 4396 475 to 13   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 463/468
(98 %)
6 diff
(98.8 %id)
AA663787 schizophrenic brain S-11 frontal lobe .f-u 3944 to 4363 419 to 1       419/419
(100 %)
2 diff
(99.6 %id)
W60611 Pancreas, pancreatic islet .f-u 3949 to 4284 345 to 1       345/350
(98 %)
13 diff
(96.3 %id)
CA448957 Chondrosarcoma, Left Pelvis .f-u 3951 to 4391 463 to 23       441/463
(95 %)
0 diff
(100 %id)
AI858035 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .f-u 3953 to 4397 453 to 9       445/453
(98 %)
0 diff
(100 %id)
AI963410.
matches multiple genes
adenocarcinoma, Pancreas .f-u 3954 to 4364 460 to 49   tiling clone, AAA also hits gene kawto 412/444
(92 %)
0 diff
(100 %id)
AI697115 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .f-u 3958 to 4239 282 to 1       282/282
(100 %)
0 diff
(100 %id)
AI568022 adenocarcinoma, Pancreas .f-u 3958 to 4397 441 to 1       441/441
(100 %)
3 diff
(99.4 %id)
AI955742 adenocarcinoma, Pancreas .f-u 3958 to 4394 438 to 1       438/438
(100 %)
3 diff
(99.4 %id)
AI679570 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .f-u 3959 to 4239 281 to 1       281/281
(100 %)
0 diff
(100 %id)
AI679579 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .f-u 3961 to 4239 279 to 1       279/279
(100 %)
0 diff
(100 %id)
AW089595 ovary, tumor, 5 pooled (see description) .f-u 3965 to 4239 275 to 1       275/275
(100 %)
0 diff
(100 %id)
AI339063 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .f-u 3967 to 4393 427 to 1       427/427
(100 %)
5 diff
(98.9 %id)
AA065103   .f-u 3984 to 4203 1 to 220   fully sequenced,   220/220
(100 %)
1 diff
(99.6 %id)
AA858152 epithelium (cell line), Prostate .f-u 4002 to 4393 392 to 1       392/392
(100 %)
1 diff
(99.8 %id)
AI432924 lymph node, lymphoma, follicular mixed small and largecell .f-u 4010 to 4397 390 to 3       388/390
(99 %)
0 diff
(100 %id)
AI624019 adenocarcinoma, Pancreas .f-u 4010 to 4396 407 to 21   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 387/387
(100 %)
5 diff
(98.8 %id)
AA126880 colon, tumor .f-u 4014 to 4396 384 to 1   fully sequenced,   384/384
(100 %)
1 diff
(99.8 %id)
CA314339 Human Lung Epithelial cells, lung .f-u 4022 to 4391 388 to 19   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 370/373
(99 %)
5 diff
(98.7 %id)
AI445458 adenocarcinoma, Pancreas .f-u 4032 to 4397 370 to 5       366/370
(98 %)
0 diff
(100 %id)
H28210 breast .f-u 4034 to 4384 365 to 10       356/440
(80 %)
0 diff
(100 %id)
AW135563   .f-u 4037 to 4393 374 to 18   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 357/366
(97 %)
1 diff
(99.8 %id)
AA625444 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .f-u 4038 to 4396 1 to 359       359/359
(100 %)
3 diff
(99.2 %id)
AI125724   .f-u 4042 to 4395 357 to 4       354/357
(99 %)
0 diff
(100 %id)
AA262977 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .f-u 4054 to 4393 340 to 1       340/340
(100 %)
1 diff
(99.8 %id)
AI337013 pooled germ cell tumors .f-u 4070 to 4393 324 to 1       324/324
(100 %)
1 diff
(99.7 %id)
AI656386 pooled germ cell tumors .f-u 4070 to 4393 324 to 1       324/324
(100 %)
1 diff
(99.7 %id)
AW193654 pooled germ cell tumors .f-u 4070 to 4393 324 to 1       324/324
(100 %)
1 diff
(99.7 %id)
AA932682 pooled germ cell tumors .f-u 4073 to 4396 324 to 1       324/324
(100 %)
1 diff
(99.7 %id)
AI680008 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .f-u 4080 to 4239 160 to 1       160/160
(100 %)
0 diff
(100 %id)
AI680016 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .f-u 4080 to 4239 160 to 1       160/160
(100 %)
0 diff
(100 %id)
AI432960 adenocarcinoma, Pancreas .f-u 4089 to 4395 307 to 1       307/308
(99 %)
0 diff
(100 %id)
AI678398 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .f-u 4089 to 4239 151 to 1       151/151
(100 %)
1 diff
(99.4 %id)
AI537798 serous papillary carcinoma, high grade, 2pooled tumors, uterus .f-u 4091 to 4239 149 to 1       149/149
(100 %)
1 diff
(99.4 %id)
AI863576 2 pooled tumors (clear cell type), Kidney .f-u 4127 to 4397 273 to 3       271/274
(98 %)
0 diff
(100 %id)
AI928629.
matches multiple genes
anaplastic oligodendroglioma, brain .f-u 4147 to 4396 267 to 18   tiling clone, AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base), also hits gene kawto 250/250
(100 %)
5 diff
(98.0 %id)
R48451 breast .f-u 4156 to 4395 247 to 3       245/256
(95 %)
0 diff
(100 %id)
AA689570 pooled germ cell tumors .f-u 4157 to 4394 239 to 1       239/239
(100 %)
2 diff
(99.2 %id)
AI968484 pooled germ cell tumors .f-u 4160 to 4396 237 to 1       237/237
(100 %)
3 diff
(98.8 %id)
AW197544 pooled germ cell tumors .f-u 4160 to 4396 237 to 1       237/237
(100 %)
1 diff
(99.6 %id)
AW589789 pooled germ cell tumors .f-u 4160 to 4395 238 to 3       236/238
(99 %)
0 diff
(100 %id)
AA064853   .f-u 4173 to 4369 197 to 1   fully sequenced,   197/197
(100 %)
1 diff
(99.5 %id)
BF197809 skin, normal, 4 pooled samples .f-u 4253 to 4393 141 to 1       141/141
(100 %)
0 diff
(100 %id)
AA758313   .f-u 4280 to 4397 119 to 2       118/119
(99 %)
0 diff
(100 %id)
BI055244 placenta_normal .g 1 to 180 18 to 194   tiling clone,   177/208
(85 %)
6 diff
(97.2 %id)
BI055249 placenta_normal .g 2 to 313 18 to 324   tiling clone,   307/324
(94 %)
6 diff
(98.2 %id)
DA335887 hippocampus .h 1 to 582 2 to 583   tiling clone, capped   582/582
(100 %)
0 diff
(100 %id)
DA134709 alzheimer cortex .i 1 to 542 7 to 548 I69T tiling clone, capped   547/547
(100 %)
1 diff
(99.9 %id)
DB164730 thymus .j 1 to 575 2 to 576 exact tiling clone, capped   575/575
(100 %)
1 diff
(99.9 %id)
DB114527 thymus .k 1 to 557 2 to 558 exact tiling clone, capped   557/557
(100 %)
3 diff
(99.5 %id)
DB139147 thymus .l 1 to 536 2 to 538 exact tiling clone, capped   537/537
(100 %)
4 diff
(99.3 %id)
BQ367888 placenta_normal .m 1 to 291 1 to 288 S5A H6I S7D I8T P9H ... tiling clone,   288/288
(100 %)
16 diff
(94.5 %id)
DA012900 adrenal gland Gene TBC1D2B, variant not shown       capped Suspected internal deletion, this clone was ignored    
BP208952 cerebellum Gene TBC1D2B, variant not shown         This clone was ignored    
CN365370 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells Gene TBC1D2B, variant not shown              
DR004779 placenta Gene TBC1D2B, variant not shown         This clone was ignored    
TI_2194695409   Gene TBC1D2B, variant not shown         This clone was ignored    
TI_2194695426   Gene TBC1D2B, variant not shown         This clone was ignored    
BE906072 epithelioid carcinoma, Pancreas Gene TBC1D2B, variant not shown         Suspected internal deletion, this clone was ignored    
BI770447 pooled lung and spleen Gene TBC1D2B, variant not shown              
CD252111 White Matter Gene TBC1D2B, variant not shown              
TI_57179717   Gene TBC1D2B, variant not shown              
DA945482 Spleen Gene TBC1D2B, variant not shown       capped      
DB333484 Spleen Gene TBC1D2B, variant not shown              
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f-u, .g, .h, .i, .j, .k, .l, .m Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes C